AAAAAA
Results:
1-8
|
Results: 8
Authors:
Gissmann, L
Osen, W
Muller, M
Jochmus, I
Citation: L. Gissmann et al., Therapeutic vaccines for human papillomaviruses, INTERVIROLO, 44(2-3), 2001, pp. 167-175
Authors:
Osen, W
Peiler, T
Ohlschlager, P
Caldeira, S
Faath, S
Michel, N
Muller, M
Tommasino, M
Jochmus, I
Gissmann, L
Citation: W. Osen et al., A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity, VACCINE, 19(30), 2001, pp. 4276-4286
Authors:
Kaufmann, AM
Nieland, J
Schinz, M
Nonn, M
Gabelsberger, J
Meissner, H
Muller, RT
Jochmus, I
Gissmann, L
Schneider, A
Durst, M
Citation: Am. Kaufmann et al., HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination, INT J CANC, 92(2), 2001, pp. 285-293
Authors:
Osen, W
Jochmus, I
Muller, M
Gissmann, L
Citation: W. Osen et al., Immunization against human papillomavirus infection and associated neoplasia, J CLIN VIRO, 19(1-2), 2000, pp. 75-78
Authors:
Borchers, A
Braspenning, J
Meijer, J
Osen, W
Gissmann, L
Jochmus, I
Citation: A. Borchers et al., E7-specific cytotoxic T cell tolerance in HPV-transgenic mice, ARCH VIROL, 144(8), 1999, pp. 1539-1556
Authors:
Jochmus, I
Schafer, K
Faath, S
Muller, M
Gissmann, L
Citation: I. Jochmus et al., Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16)as a prophylactic and therapeutic vaccine, ARCH MED R, 30(4), 1999, pp. 269-274
Authors:
Schafer, K
Muller, M
Faath, S
Henn, A
Osen, W
Zentgraf, H
Benner, A
Gissmann, L
Jochmus, I
Citation: K. Schafer et al., Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection, INT J CANC, 81(6), 1999, pp. 881-888
Authors:
Schneider, A
Durst, M
Jochmus, I
Gissmann, L
Citation: A. Schneider et al., Epidemiology, aetiology and prevention of carcinoma of the cervix, GYNAKOLOGE, 32(4), 1999, pp. 247-260
Risultati:
1-8
|